Business and Finance News

US tax inversion move may scuttle Pfizer’s plan to become Irish

The US Treasury Department on Monday made its third attempt in recent years to curb US companies from moving their headquarters/ tax domicile to foreign countries to save tax. The move may scuttle the $160 billion deal between Pfizer Inc., the US drugs giant, and the already Irish, Allergan PLC, which makes Botox among other remedies, and is run from the United States but board meetings are held in Dublin.

Previous ArticleNext Article